Unravelling the role of AKR1D1 in human hepatocytes
<p>Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and is rapidly becoming one of the leading indications for liver transplantation worldwide. The cellular processes and molecular targets that govern disease development and progression remain to...
Main Author: | Nikolaou, N |
---|---|
Other Authors: | Hodson, L |
Format: | Thesis |
Published: |
2017
|
Similar Items
-
AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease.
by: Nikolaou, N, et al.
Published: (2019) -
Structure-activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4.
by: Lee, W, et al.
Published: (2009) -
Structure-activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4.
by: Lee, W, et al.
Published: (2009) -
Human and murine steroid 5β-reductases (AKR1D1 and AKR1D4): Insights into the role of the catalytic glutamic acid
by: Chen, M, et al.
Published: (2019) -
Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo
by: Nikolaou, N, et al.
Published: (2020)